Log In
Print
BCIQ
Print
Print this Print this
 

ML7

  Manage Alerts
Collapse Summary General Information
Company Neuroptis Biotech
DescriptionMyosin light chain kinase (MYLK; MLCK) inhibitor
Molecular Target Myosin light chain kinase (MYLK) (MLCK)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDry eye
Indication DetailsTreat ocular surface diseases, including dry eye syndrome
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today